Pharmaceuticals, Biotechnology and Life Sciences
First and only immunotherapy plus ADC regimen, used perioperatively, to extend survival for cisplatin-eligible patients with MIBC RAHWAY, N.J.–(BUSINESS WIRE)–Merck…
NEW YORK–(BUSINESS WIRE)–Kallyope, a late-stage biotechnology company leveraging unique insights into neural signaling pathways to develop innovative therapies for health…
Post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs, published in the Journal of the European Academy…
– Vir Biotechnology to receive EUR 55 million initial reimbursement payment upon closing, and up to EUR 495 million in…
MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on…
City of Hope’s float, “Overcoming Cancer and Diabetes Together,” joins the 137th Rose Parade and will carry six riders in…
ARLINGTON, Va.–(BUSINESS WIRE)–Recognizing that research facilities use five to 10 times as much energy as office buildings, the International Institute…
Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the World WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, developer of the leading…
PITTSBURGH–(BUSINESS WIRE)–#CytoAgents—CytoAgents, Inc. a clinical-stage biotechnology company developing CTO1681, a novel, steroid-sparing inhibitor of prostaglandin-mediated inflammation, announced today the appointment…
100% of mice treated with a single intravenous dose of VV169 saw complete clearance of disseminated myeloma tumors within 28…